Kepley BioSystems offers ocean restorative technology to help stem the continued depletion of wild fish.
Kepley BioSystems has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in December 2022.
Kepley BioSystems's investors include National Science Foundation, North Carolina Biotechnology Center, NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR).
Kepley BioSystems is headquartered in Greensboro, United States.
Kepley BioSystems offers ocean restorative technology to help stem the continued depletion of wild fish.
Kepley BioSystems is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kepley BioSystems — Funding & Investors." VCBacked, December 13, 2022, https://www.vcbacked.co/company/kepley-biosystems. Accessed November 14, 2026.
VCBacked. (2022). Kepley BioSystems — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/kepley-biosystems
{{cite web |title=Kepley BioSystems — Funding & Investors |url=https://www.vcbacked.co/company/kepley-biosystems |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Kepley BioSystems? Request a listing update